![Philip Chase](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Chase
Vorstandsvorsitzender bei
Adimab LLC
Profil
Philip T.
Chase is Chief Executive Officer at Adimab LLC since 2022.
Former roles include Director at Invivyd, Inc., Vice President & General Counsel at EPIX Pharmaceuticals, Inc., Chief Corporate Counsel at Transkaryotic Therapies, Inc., Vice President & General Counsel at RenaMed Biologics, Inc., and Vice President-Legal Affairs at Alnylam Pharmaceuticals, Inc. Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at Colby College.
Aktive Positionen von Philip Chase
| Unternehmen | Position | Beginn |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | Vorstandsvorsitzender | 01.04.2022 |
Ehemalige bekannte Positionen von Philip Chase
| Unternehmen | Position | Ende |
|---|---|---|
| INVIVYD, INC. | Direktor/Vorstandsmitglied | - |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | General Counsel | - |
| ALNYLAM PHARMACEUTICALS, INC. | General Counsel | - |
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services Provided clinical cellular therapy | General Counsel | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | General Counsel | - |
Ausbildung von Philip Chase
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services Provided clinical cellular therapy | Health Services |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
